Market Research Industry Reports

Quark Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Quark Pharmaceuticals, Inc. (Quark) is a clinical stage pharmaceutical company that discovers and develops therapeutic RNAi drug candidates. The companys products include PF-655, a synthetic siRNA which is used for the treatment of diabetic macular edema and age-related macular degeneration; QPI-1002, a synthetic siRNA which is designed for the treatment of acute kidney injury and delayed graft function; QPI-1007, a synthetic siRNA which is used for the treatment of ocular neuroprotection and non-arteritic anterior ischemic optic neuropathy; and others. The company has its facilities in Israel and the US. It has licensing partnership with Pfizer, Inc.; Nitto Denko Corporation; and others. Quark is headquartered in Fremont, California, the US.

Quark Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 3
List of Figures 4
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Quark Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Quark Pharma Raises US$10 Million In Venture Financing 11
Partnerships 12
Quark Pharma Enters into Agreement with Transplant Genomics 12
Suzhou Ribo Life Science Forms Joint Venture With Quark Pharma 13
Nitto Denko Enters Into Co-Development Agreement With Quark Pharma 14
Licensing Agreements 15
Biocon And Quark Pharma Enter Into Agreement To Develop siRNA Based Therapeutics 15
Quark Pharma Amends Licensing Agreement With Pfizer For PF-655 16
Quark Pharma Enters Into Option Licensing Agreement With Novartis Pharma For QPI-1002 18
Quark Pharma Enters into Licensing Agreement with GE Healthcare Dharmacon 20
Equity Offering 21
Quark Biotech Withdraws IPO Of Units For US$20 Million 21
Quark Pharmaceuticals, Inc. - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables


Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Quark Pharmaceuticals, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Quark Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Quark Pharma Raises US$10 Million In Venture Financing 11
Quark Pharma Enters into Agreement with Transplant Genomics 12
Suzhou Ribo Life Science Forms Joint Venture With Quark Pharma 13
Nitto Denko Enters Into Co-Development Agreement With Quark Pharma 14
Biocon And Quark Pharma Enter Into Agreement To Develop siRNA Based Therapeutics 15
Quark Pharma Amends Licensing Agreement With Pfizer For PF-655 16
Quark Pharma Enters Into Option Licensing Agreement With Novartis Pharma For QPI-1002 18
Quark Pharma Enters into Licensing Agreement with GE Healthcare Dharmacon 20
Quark Biotech Withdraws IPO Of Units For US$20 Million 21
Quark Pharmaceuticals, Inc., Key Competitors 22
Quark Pharmaceuticals, Inc., Key Employees 23
Quark Pharmaceuticals, Inc., Other Locations 24

List Of Figures


Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Quark Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Quark Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9

Quark Pharmaceuticals Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Quark Pharmaceuticals Inc (Quark), a subsidiary of SBI Biotech Co Ltd, is a clinical-stage pharmaceutical company in the development of novel RNAi-based therapeutics. It offers under development products which include

USD 250View Report

Fromage Frais & Quark (Dairy & Soy Food) Market in the United Kingdom - Outlook to 2021: Market Size, Growth and Forecast Analytics

Fromage Frais & Quark (Dairy & Soy Food) Market in the United Kingdom - Outlook to 2021: Market Size, Growth and Forecast AnalyticsFromage Frais & Quark (Dairy & Soy Food)

USD 500View Report

Sagent Pharmaceuticals, Inc. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Sagent Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350View Report

Progenics Pharmaceuticals, Inc. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Progenics Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Progenics Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2016
No. of Pages :25
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube